Mereo BioPharma (MREO) Payables (2017 - 2026)
Mereo BioPharma's Payables was $1.12 million in Q2 2026, down 1.5% from $1.14 million a year earlier and down 65.3% from the prior quarter.
Powered by 
Analysis
Mereo BioPharma (MREO) Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Payables at Mereo BioPharma came in at $1.33 million, down 83.3% from FY2024.
- Payables shows a five-year compound annual growth rate of -21.2% (FY2020 to FY2025).
- In earlier years, Payables was $7.98 million in FY2024 (+239.9%), $2.35 million in FY2023 (-85.9%), $16.61 million in FY2022 (+393.1%) and $3.37 million in FY2021 (-23.5%).
- Quarterly Payables has moved between $879,000 (Q3 2025) and $16.61 million (Q4 2022) over five years.
- Compared with a year earlier, Payables was higher in two of the last seven quarters, with an average decline of 9.5%.
- The best year-over-year quarter for Payables over five years was Q4 2022 (growth of 393.1%); the worst was Q3 2025 (a decline of 88.0%).
- Per Business Quant data, MREO's Payables in the three quarters before Q2 2026 was $3.23 million (Q1 2026), $1.33 million (Q4 2025) and $879,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Mereo BioPharma | 46.45 Mn | -103.46 Mn | - | 1.12 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.12 Mn |
| Mar 31, 2026 | 3.23 Mn |
| Dec 31, 2025 | 1.33 Mn |
| Sep 30, 2025 | 879,000.00 |
| Jun 30, 2025 | 1.14 Mn |
| Mar 31, 2025 | 2.92 Mn |
| Dec 31, 2024 | 7.98 Mn |
| Sep 30, 2024 | 7.30 Mn |
| Jun 30, 2024 | 7.63 Mn |
| Mar 31, 2024 | 7.09 Mn |
| Dec 31, 2023 | 2.35 Mn |
| Jun 30, 2023 | 7.69 Mn |
| Dec 31, 2022 | 17.08 Mn |
| Jun 30, 2022 | 3.42 Mn |
| Dec 31, 2021 | 3.37 Mn |
| Jun 30, 2021 | 3.03 Mn |
| Dec 31, 2020 | 4.54 Mn |
| Jun 30, 2020 | 23.07 Mn |
| Dec 31, 2019 | 28.18 Mn |
| Jun 30, 2019 | 18.72 Mn |
API Access
Mereo BioPharma Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=MREO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "MREO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=MREO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();